Redmond Asset Management, LLC Bio Techne Corp Transaction History

Redmond Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 07, 2019	SELL	$183.56 - $216.72 $1.34 Million - $1.58 Million	-7,274 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$188.72 - $215.43 $739,216 - $843,839	-3,917 Reduced 35.0%	7,274 $1.52 Million
Q1 2019 Apr 24, 2019	SELL	$136.09 - $200.44 $6,668 - $9,821	-49 Reduced 0.44%	11,191 $2.22 Million
Q4 2018 Feb 06, 2019	SELL	$132.75 - $203.8 $43,143 - $66,235	-325 Reduced 2.81%	11,240 $1.63 Million
Q3 2018 Nov 13, 2018	SELL	$147.44 - $204.11 $319,207 - $441,898	-2,165 Reduced 15.77%	11,565 $2.36 Million

Q2 2018 Aug 09, 2018	SELL	$144.9 - $165.58 $16,663 - $19,041	-115 Reduced 0.83%	13,730 $2.03 Million
Q1 2018 May 07, 2018	SELL	$131.46 - $151.04 $94,256 - $108,295	-717 Reduced 4.92%	13,845 $2.09 Million
Q4 2017 Feb 02, 2018	SELL	$121.17 - $134.75 $61,796 - $68,722	-510 Reduced 3.38%	14,562 $1.89 Million
Q3 2017 Nov 06, 2017	SELL	$113.59 - $123.78 $6,247 - $6,807	-55 Reduced 0.36%	15,072 $1.82 Million
Q2 2017 Aug 14, 2017	BUY	N/A	15,127	15,127 $1.78 Million

581

154M

180K

189K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.79B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmond Asset Management, LLC with notifications on news.